Prem Premsrirut
Directeur Général chez Mirimus, Inc.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Robert van Nostrand | M | 67 |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Cynthia Green | M | - |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Barry W. Weiner | M | 73 |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Aaron Etra | M | 83 |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Robert A. Cantone | M | - |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Donald Mazzullo | M | - |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Dan Brettler | M | - |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Richard Catalano | M | 64 |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Lily Safani | F | - |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Hala Mirza | F | - |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Robert G. Urban | M | - |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Ellen Corenswet | F | - |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Peter G. Robinson | M | - |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Edgar H. Haug | M | - |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Joel I. Papernik | M | - |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Arthur H. Tinkelenberg | M | 57 |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Todd F. Little | M | - |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Steven J. Winick | M | - |
Mirimus, Inc.
 Mirimus, Inc. Medical SpecialtiesHealth Technology Mirimus, Inc. is a private company based in Brooklyn, NY that specializes in creating animal models for preclinical evaluation of new therapeutics. The company uses rnai and crispr technologies to develop these models and have established themselves as a leader in conducting high-volume, complex and highly effective pcr testing. Mirimus has developed SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing, and pcr diagnostics to improve the scalability, efficiency, cost-effectiveness, and accuracy of COVID-19 testing. The company was founded in 2010 by Stephen Elledge, Prem Premsrirut, Lukas Dow, Christof Fellman, Greg Hannon, Scott W. Lowe, Johannes Zuber, and Prem Premsrirut has been the CEO since 2010. | - |
| Gregory D. Plowman | M | - |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Joel Marcus | M | 76 |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | - |
| Gerard Garramone | M | - |
Mirimus, Inc.
Mirimus, Inc. Medical SpecialtiesHealth Technology Mirimus, Inc. is a private company based in Brooklyn, NY that specializes in creating animal models for preclinical evaluation of new therapeutics. The company uses rnai and crispr technologies to develop these models and have established themselves as a leader in conducting high-volume, complex and highly effective pcr testing. Mirimus has developed SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing, and pcr diagnostics to improve the scalability, efficiency, cost-effectiveness, and accuracy of COVID-19 testing. The company was founded in 2010 by Stephen Elledge, Prem Premsrirut, Lukas Dow, Christof Fellman, Greg Hannon, Scott W. Lowe, Johannes Zuber, and Prem Premsrirut has been the CEO since 2010. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Stephen Elledge | M | - |
Mirimus, Inc.
Mirimus, Inc. Medical SpecialtiesHealth Technology Mirimus, Inc. is a private company based in Brooklyn, NY that specializes in creating animal models for preclinical evaluation of new therapeutics. The company uses rnai and crispr technologies to develop these models and have established themselves as a leader in conducting high-volume, complex and highly effective pcr testing. Mirimus has developed SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing, and pcr diagnostics to improve the scalability, efficiency, cost-effectiveness, and accuracy of COVID-19 testing. The company was founded in 2010 by Stephen Elledge, Prem Premsrirut, Lukas Dow, Christof Fellman, Greg Hannon, Scott W. Lowe, Johannes Zuber, and Prem Premsrirut has been the CEO since 2010. | - |
| Christof Fellman | M | - |
Mirimus, Inc.
Mirimus, Inc. Medical SpecialtiesHealth Technology Mirimus, Inc. is a private company based in Brooklyn, NY that specializes in creating animal models for preclinical evaluation of new therapeutics. The company uses rnai and crispr technologies to develop these models and have established themselves as a leader in conducting high-volume, complex and highly effective pcr testing. Mirimus has developed SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing, and pcr diagnostics to improve the scalability, efficiency, cost-effectiveness, and accuracy of COVID-19 testing. The company was founded in 2010 by Stephen Elledge, Prem Premsrirut, Lukas Dow, Christof Fellman, Greg Hannon, Scott W. Lowe, Johannes Zuber, and Prem Premsrirut has been the CEO since 2010. | - |
| Greg Hannon | M | - |
Mirimus, Inc.
Mirimus, Inc. Medical SpecialtiesHealth Technology Mirimus, Inc. is a private company based in Brooklyn, NY that specializes in creating animal models for preclinical evaluation of new therapeutics. The company uses rnai and crispr technologies to develop these models and have established themselves as a leader in conducting high-volume, complex and highly effective pcr testing. Mirimus has developed SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing, and pcr diagnostics to improve the scalability, efficiency, cost-effectiveness, and accuracy of COVID-19 testing. The company was founded in 2010 by Stephen Elledge, Prem Premsrirut, Lukas Dow, Christof Fellman, Greg Hannon, Scott W. Lowe, Johannes Zuber, and Prem Premsrirut has been the CEO since 2010. | - |
| Scott W. Lowe | M | - |
Mirimus, Inc.
Mirimus, Inc. Medical SpecialtiesHealth Technology Mirimus, Inc. is a private company based in Brooklyn, NY that specializes in creating animal models for preclinical evaluation of new therapeutics. The company uses rnai and crispr technologies to develop these models and have established themselves as a leader in conducting high-volume, complex and highly effective pcr testing. Mirimus has developed SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing, and pcr diagnostics to improve the scalability, efficiency, cost-effectiveness, and accuracy of COVID-19 testing. The company was founded in 2010 by Stephen Elledge, Prem Premsrirut, Lukas Dow, Christof Fellman, Greg Hannon, Scott W. Lowe, Johannes Zuber, and Prem Premsrirut has been the CEO since 2010. | - |
| Lukas Dow | M | - |
Mirimus, Inc.
Mirimus, Inc. Medical SpecialtiesHealth Technology Mirimus, Inc. is a private company based in Brooklyn, NY that specializes in creating animal models for preclinical evaluation of new therapeutics. The company uses rnai and crispr technologies to develop these models and have established themselves as a leader in conducting high-volume, complex and highly effective pcr testing. Mirimus has developed SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing, and pcr diagnostics to improve the scalability, efficiency, cost-effectiveness, and accuracy of COVID-19 testing. The company was founded in 2010 by Stephen Elledge, Prem Premsrirut, Lukas Dow, Christof Fellman, Greg Hannon, Scott W. Lowe, Johannes Zuber, and Prem Premsrirut has been the CEO since 2010. | - |
| Johannes Zuber | M | - |
Mirimus, Inc.
Mirimus, Inc. Medical SpecialtiesHealth Technology Mirimus, Inc. is a private company based in Brooklyn, NY that specializes in creating animal models for preclinical evaluation of new therapeutics. The company uses rnai and crispr technologies to develop these models and have established themselves as a leader in conducting high-volume, complex and highly effective pcr testing. Mirimus has developed SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing, and pcr diagnostics to improve the scalability, efficiency, cost-effectiveness, and accuracy of COVID-19 testing. The company was founded in 2010 by Stephen Elledge, Prem Premsrirut, Lukas Dow, Christof Fellman, Greg Hannon, Scott W. Lowe, Johannes Zuber, and Prem Premsrirut has been the CEO since 2010. | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 27 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Prem Premsrirut
- Réseau Personnel
